Bob Dagher
Chief Tech/Sci/R&D Officer at BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 123 211 $ as of 2024-05-30
Bob Dagher active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2024-04-15 | - |
| Corporate Officer/Principal | 2023-07-16 | 2024-04-15 |
Career history of Bob Dagher
Former positions of Bob Dagher
| Companies | Position | Start | End |
|---|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-12-05 | 2022-12-31 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2019-11-30 | 2021-11-30 |
| COVANCE INC. | Chief Tech/Sci/R&D Officer | 2017-12-31 | 2018-12-31 |
| MedAvante-ProPhase, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Training of Bob Dagher
| Université de Bordeaux | Undergraduate Degree |
| Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
Statistics
International
| United States | 6 |
| France | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
| MedAvante-ProPhase, Inc. |
- Stock Market
- Insiders
- Bob Dagher
- Experience
